Forward PE Ratio: 39.74
The forward PE ratio is 39.74 as of Thursday, July 9, 2026.
Forward PE Ratio (39.74) = Close Price ($411.55) / Consensus Forward EPS ($10.45)
ISRG Forward PE Ratio Metrics
FORWARD PE RATIO
39.74
ISRG Competitors' Forward PE Ratio
Intuitive Surgical, Inc.
Market Cap
$145.76B
Forward PE Ratio
39.74
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Intuitive Surgical, Inc. (ISRG) | $145.76B | 39.74 |
| Danaher Corporation (DHR)vs › | $138.71B | 22.58 |
| Pfizer Inc. (PFE)vs › | $138.21B | 8.14 |
| CVS Health Corp. (CVS)vs › | $131.18B | 14.08 |
| Abbott Laboratories (ABT)vs › | $164.43B | 17.39 |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $126.01B | 25.80 |
| Stryker Corporation (SYK)vs › | $125.40B | 21.82 |
| Gilead Sciences, Inc. (GILD)vs › | $167.41B | N/A |
| Bristol-Myers Squibb Company (BMY)vs › | $118.32B | 9.11 |
| Medtronic plc (MDT)vs › | $105.46B | 14.86 |
Trailing vs Forward
Trailing P/E
50.3
reported TTM EPS
Forward P/E
39.7
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $10.45 implies +26.7% EPS growth vs the reported trailing $8.25.
Forward P/E by Fiscal Year
View All Analyst EstimatesAt today's $411.55 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $10.45 | $10.18 – $10.64 | 17 | 39.4x |
| 2027-12-31 | $11.84 | $11.47 – $12.32 | 18 | 34.8x |
| 2028-12-31 | $13.43 | $11.79 – $14.61 | 10 | 30.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
Forward PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Forward PE Ratio FAQ
- What is the forward PE ratio for Intuitive Surgical, Inc. (ISRG)?
- The forward PE ratio for ISRG stock is 39.74.
Related Metrics
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David J. Rosa